ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q4 2021 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q4 2021 Earnings Conference Call March 10, 2022 05:00 PM ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President & Chief Executive Officer Salim Yazji - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer Carl Byrnes - Northland Capital Markets Kaveri Pohlman - BTIG Robert Burns - H.C. Wainwright Shubhendu Sen Roy - Brookline Capital Markets Presentation Operator Greetings and welcome to Oncternal Therapeutics Inc. Q4 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Richard Vincent, CFO of Oncternal Therapeutics Inc. Please, go ahead, sir. Richard Vincent Thank you, Peter. Good afternoon, everyone, and thank you for joining us today. Joining me on
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q4 2021 Results - Earnings Call Transcript